Celumigen Pharmaceuticals develops innovative prescription treatmentsand novel drug delivery systems for conditions and diseases of the skin.Our novel, patented 505 (b) (2) treatment is targeting multiple indications in cutaneous viral disease, each one representing a large patient population with a significant unmet need.